-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
January 15, 2013 - Control
(IDC)
Inclusion Criteria:
PKU dx within first 2 weeks
of birth, and treated early(<1
month … follow-up; death due to
cause unrelated to PKU
Age, mean/yrs±SD (range):
Median age 16 years, range 1
month
-
effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
January 01, 2012 - It is removed at the end of the 6-
month period.
16,19
A phase III trial of the implant was recently … Titan Pharmaceuticals announces positive results
of six-month open-label safety retreatment study
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
September 18, 2012 - Protocol Amendment - Safety of Vaccines 030413
1
Source: www:effectivehealthcare.ahrq.gov
Originally published online: October 22, 2012; Republished: March 25, 2013
Evidence-based Practice Center Systematic Review Protocol
Safety of Vaccines Used for Routine Immunizatio…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
March 15, 2016 - for this latter
number is not presented - is it the 96
patients (91%) listed as "completing the 12
month … Long term outcomes were
defined as greater than one month. … Long term outcomes were
defined as greater than one month. … with sUA levels of 4.1-5.0 mg/dL had their tophi reduced by 0.99 ± 0.50
mm/month
- 20 patients with … sUA levels ≤4.0 mg/dl showed a velocity of reduction of tophi of 1.52
±
0.67 mm/month
• There
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
January 01, 2024 - months prior to screening and consumption of pre- or probiotics or any fibre supplement during the last month … prior to screening, any unexplained weight loss or weight gain of >5 kg in the 1 month prior to the … antibiotics, for at least 6 months before the study began, prebiotics and pro-
biotics or laxatives within 1 month … times/wk; written informed consent prior to the study Cereal intake > 3 times/wk, medication within a month … months prior to the study; use of probiotic, prebiotic, or synbiotic products > twice a week in the month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
January 01, 2024 - months prior to the study; use of probiotic, prebiotic, or synbiotic products > twice a week in the month … months prior to screening and consumption of pre- or probiotics or any fibre supplement during the last month … prior to screening, any unexplained weight loss or weight gain of >5 kg in the 1 month prior to the … antibiotics, for at least 6 months before the study began, prebiotics and pro-
biotics or laxatives within 1 month … times/wk; written informed consent prior to the study Cereal intake > 3 times/wk, medication within a month
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/wic-outcomes-nutrition-protocol-amended.pdf
October 01, 2020 - provisions
from 2009 onwards (year and location), defined
at a minimum as enrolling in WIC for one month … provisions
from 2009 onwards (year and location),
defined at a minimum as enrolling in WIC for
one month
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
November 01, 2016 - non-menstrual pelvic pain (NMPP) and menstrual
pain (or dysmenorrhea), associated with endometriosis, at month … three, as well as
month six, as measured by the Daily Assessment of Endometriosis Pain scale.
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
November 01, 2016 - non-menstrual pelvic pain (NMPP) and menstrual
pain (or dysmenorrhea), associated with endometriosis, at month … three, as well as
month six, as measured by the Daily Assessment of Endometriosis Pain scale.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-immunodeficiency-virus-rapid-response.pdf
May 01, 2025 - NSPT with
ultrasonic
scaler; then
supragingival
prophylaxis and
OHI weekly
during the 1st
month … then
monthly until the
6th month
CD4 count
Viral load
3.2.2 Results, Key Question 1, Included … HIV
patients include pre-treatment antibacterial mouth rinses, regular
periodontal exams, and six-month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
April 18, 2013 - Three estimates used migraine
that occurred ≥15 days per month, with
prevalence ranging from 0 to 0.7% … questions after
considering public comments (the questions
were posted in the AHRQ website for 1 month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_executive.pdf
May 01, 2013 - weight loss when not
dieting, weight gain (e.g., change of
more than 5 percentof body weight in
a month … for
major depression alone and 14.5 percent for major and
minor depression, with a cumulative 12-month … doctor visits
for their infants up to 6 months, but this difference was not
significant in the 6–12-month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-protocol.pdf
June 20, 2024 - Timing KQ 5 and 6
• Serious harms - periprocedural
KQ 5
9
Inclusion Exclusion
• 3-month … and 6-month periods following
the procedure
KQ 6
• Outcomes measured at 3, 6 and ≥ 12
months
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Thus,
without these programs, the reported cost after the 14-day introduction is about $160 per
month … which patients
can receive a 15-day free supply, for a reported savings of $100 (50% off the first month … Patients are eligible for savings of $75 per month if their health insurance copayment or out-
of-pocket … Patients’ out-of-pocket costs for phentermine-topiramate initially ranged from $120 to $185 per
month … Patients are
eligible for savings of $75 per month if their health insurance copayment or out-of-pocket
-
effectivehealthcare.ahrq.gov/sites/default/files/kravitz_eccs2012.pdf
January 01, 2012 - part of the physical examination
A refill or renewal of medication taken or prescribed in the
past month
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
July 01, 2013 - Thus, without these programs,
the reported cost after the 14-day introduction is about $160 per month … which patients can receive a 15-day free supply, for a reported
savings of $100 (50% off the first month … Patients are eligible for savings of $75 per month
if their health insurance copayment or out-of-pocket … Patients are
eligible for savings of $75 per month if their health insurance copayment or out-of-pocket … general practitioners, to prescribe the drug
electronically through local pharmacies for a three-month
-
effectivehealthcare.ahrq.gov/sites/default/files/fecal-incontinence_disposition-comments.pdf
March 21, 2016 - significantly at 3 months of 6 months but the
actual change in number of FI episodes from
baseline to 6 month … so little
longer term data available on treatment durability,
recommend adding the data for the 12-month … Conclusion
Paragraph 2 – You probably meant to say psyllium decreases
FI episode frequency by 1 per month … dietary
fiber supplementation with psyllium decreases
FI episode frequency by 2.5 per week after 1
month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
October 01, 2012 - CER # 37:
Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and
Treatment
Original release date:
January 2012
Surveillance Report:
October 2012
Key Findings:
- The conclusions for KQ2 (harms of screening) and KQ4
(harms of monitoring), KQ6 (harms of treatment) are still
considered valid
- T…
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
August 01, 2013 - administered by a clinician to an oral pill) or dosing regimens (e.g., from daily dosing to once-a-
month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
September 01, 2011 - This was a 3-
phase study (Period A) was a 4-month, open-label phase that
determined response to abatacept … The
second phase (Period B) was a 6-month, randomized, double-blind,
parallel-dosing, placebo-controlled … Only the 6-month
randomized discontinuation trial component
of this report met the inclusion criteria … 14
Levine, Loree Results (Pg 52) Reviewer requests paragraph be changed to: …preceded by a four-
month … American College of Rheumatology (ACR) Pediatric
scores (other than ACR Pediatric 75 at month 12) are